Carbon monoxide-releasing molecule-A1 (CORM-A1) improves clinical signs of experimental autoimmune uveoretinitis (EAU) in rats

Paolo Fagone(University of Catania), Ferdinando Nicoletti(University of Catania), Lucia Salvatorelli(University of Catania), Gaetano Magro(University of Catania), Katia Mangano(University of Catania), Roberto Di Marco(University of Catania), Maria Luisa Barcellona(University of Catania), Santa Mammana(University of Catania), Eugenio Cavalli(Centro Neurolesi Bonino Pulejo)
Clinical Immunology
February 19, 2015
10.1016/j.clim.2015.02.002
Cited by 41

Related Papers

Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging
|Aging|2011|707
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508
The neuropathic pain: An overview of the current treatment and future therapeutic approaches
|International Journal of Immunopathology and Pharmacology|2019|495